Showing results (151-160 of 182) with videos related to
Sort By:
Pageof 19
JMIR Research Protocols|May 26, 2025
Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC): Protocol for Multicenter Prospective Noninterventional StudyLouise Marie Cremer, Ullrich Bethe, Peter Borchmann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanomaSteven J O'Day, Alexander M M Eggermont, Vanna Chiarion-Sileni, et al.Frontiers in Public Health|September 19, 2025
Self-testing for 5 respiratory viruses in adult VACCELERATE volunteers in Germany-a pilot study on multi-pathogen rapid antigen testing to monitor community-acquired acute respiratory infectionsJulia A Nacov, Jon Salmanton-García, Sarah Grimm, et al.Molecular Cancer Therapeutics|November 18, 2021
Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent ResistanceMagda Bahcall, Cloud P Paweletz, Yanan Kuang, et al.Cell Genomics|September 9, 2022
Workshop proceedings: GWAS summary statistics standards and sharingJacqueline A L MacArthur, Annalisa Buniello, Laura W Harris, et al.Nature Communications|February 4, 2022
A role for ColV plasmids in the evolution of pathogenic Escherichia coli ST58Cameron J Reid, Max L Cummins, Stefan Börjesson, et al.The Journal of Antimicrobial Chemotherapy|February 15, 2008
Risk factors for breakthrough invasive fungal infection during secondary prophylaxisOliver A Cornely, Angelika Böhme, Dietmar Reichert, et al.Lancet (London, England)|March 25, 2008
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialBernard Nordlinger, Halfdan Sorbye, Bengt Glimelius, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2007
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015C-H Köhne, J De Greve, J T Hartmann, et al.Nature Chemical Biology|July 1, 2024
Transition transferases prime bacterial capsule polymerizationChrista Litschko, Valerio Di Domenico, Julia Schulze, et al.Pageof 19